AR consultation prompts stifling innovation concerns

Market risks

A Financial Conduct Authority consultation on appointed representatives will tackle firms "circumventing" requirements, compliance consultants told Post, though concerns have been raised around barriers to entry and innovation.

The FCA has revealed plans to consult on “cross-sector changes to improve and strengthen elements of the appointed representatives regime later this year” in a move that could lead to legal changes.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

This address will be used to create your account

What happens now on the OIC landscape post-Rabot?

After the Supreme Court rejected the insurer-led appeal against its decision on the first two cases of mixed-injury claims involving both whiplash and non-whiplash injuries, the Association of Consumer Support Organisations’ director Matthew Maxwell Scott asks: What's next?

What the future holds for AI regulation

Striking the right balance between regulatory intervention and industry autonomy is crucial to realising the full benefits of artificial intelligence while ensuring ethical, accountable, and inclusive practices within the insurance sector, argues Nutan Rajguru, Verisk UK's head of analytics.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here